People's Journal of Scientific Research
Published June 1, 2010 | Version v1
Journal article Open

Evaluation of antibacterial activity of different Ganoderma lucidum extracts

Creators

  • 1. Department of Biological Sciences, R.D. University, Jabalpur
  • 2. Centre for Scientific Research and Development, People's Group Bhanpur, Bhopal-462037 (M.P.)

Description

Bioproducts of Mushroom have multi beneficial effects for human welfare. Medicinal mushrooms are widely used as traditional medicinal ingredients for the treatment of various diseases and related health problems. Most of the medicinal extracts from mushroom are different forms of polysaccharides which strengthens the immune system with little or no side effect. Medicinal mushroom research has focused on discovery of compounds that can modulate positively or negatively the biological response of immune cells. The antimicrobial activity of various solvent extracts (40Pg/ml) of Ganoderma lucidum was tested against six species of bacteria: Escherichia coli (MTCC-443), Staphylococcus aureus (MTCC-737), Klebsiella pneumoniae (MTCC2405), Bacillus subtilis (MTCC-1789) Salmonella typhi (MTCC-531) and Pseudomonas aeruginosa (MTCC-779). Acetone extract exhibited maximum antibacterial activity (31.60±0.10), while the most susceptible bacterium observed was Klebsiella pneumoniae.

Files

3 Dr. Sadaf Qureshi.pdf

Files (41.1 kB)

Name Size Download all
md5:ba48d9c4b2ff85d51a7d3717d46169b9
41.1 kB Preview Download

Additional details

References

  • 1. Carson CR, Hammer KA, Riley TV: Broth microdilution method for determining the susceptibility of Escherichia coli and Staphylococcus aureus to the essential oil of Melaleuca alternifolia (tea tree oil). Microbios, 1995; 82(332):181-185.
  • 2. Chang ST, Buswell JA: Mushroom nutriceuticals. World Journal of Microbiology & Biotechnology, 1996;12(5):473-476
  • 3. Chang ST, Mshigeni KE: Muschroom and Human health: their growing significance as petent dietary supplements. University of Namibia, Windhoek, Namibia. 2001;pp:79.
  • 4. Cowan MM: Plant products as antimicrobial agents. Clinical Microbiology Review, 1999;12(4):564-582.
  • 5. Dulger B, Gonuz A: Antimicrobial activity of certain plants used in Turkish traditional medicine. Asian Journal of Plant Science, 2004; 3: 104-107.
  • 6. Fang QH, Zhong JJ: Submerged fermentation of higher fungus Ganoderma lucidum for production of valuable bioactive metabolites-ganoderic acid and polysaccharides. Biochemical Engineering Journal, 2002; 10: 61-65.
  • 7. Gao Y, Zhou S, Huang M, Xu A: Antibacterial and antiviral value of the genus Ganoderma P. Karst. Species (Aphyllophoromycetideae) : A review. International Journal of Medicinal Mushrooms, 2003; 5(3): 235-246.
  • 8. Ha TB, Gerhauser C, Zhang WD, Ho-Chong-Line N, Fouraste I: New lanostanoids from Ganoderma lucidum that induce NAD(P)H: quinone oxidoreductase in cultured hepalcic7 murine hepatoma cells. Planta Medica, 2000; 66(7): 681- 684
  • 9. Keypour S, Riahi H, Moradali MF, Rafati H: Investigation of the antibacterial activity of a chloroform extract of Ling Zhi or Reishi Medicinal Mushroom, Ganoderma lucidum (W.Curt.: Fr) P. Karst. (Aphyllophoromycetideae) from Iran. International Journal of Medicinal Mushrooms, 2008; 10(4): 345-349.
  • 10. Kim HW, Kim BK: Recent advances on the biologically active triterpenoids of Ganoderma lucidum. In: Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics. ZB Lin (Ed), Beijing Medical University Press, Beijing, 2002, pp: 10-19.
  • 11. Klaus A, Miomir N: Influence of the extracts isolated from Ganoderma lucidum mushroom on some microorganisms. Proceedings of National Science, Matica Srpska Novi Sad, 2007; 113: 219-226.
  • 12. Leung SWS, Yeung KY, Ricky YLS, Man YK: Lingzhi (Ganoderma) research the past, present and future perspectives. In: Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics. ZB Lin (Ed), Beijing medical University Press, Beijing 2002; pp:1-9.
  • 13. Lin JY, Chou TB: Isolation and Characterization of a lectin from edible mushroom, Volvariella volvacea. The Journal of Biological Chemistry;1984; 96(1):35-40.
  • 14. Mothana RAA, Jansen R, Julich WD, Lindequist U: Ganomycin A and B, new antimicrobial farnesyl hydroquinones from the basidiomycete Ganoderma pfifferi. Journal of Natural Products, 2000; 63(3): 416-418.
  • 15. Oei P: Spawn production. In: Small scale mushroom cultivation. Janna de Feijter (Ed), Ist Edn; Digigrafi Wageningen International, Netherlands, 2005, pp:24-25.
  • 16. Sheena N, Ajith TA, Mathew A, Janardhanan KK: Antibacterial activity of three macrofungi, Ganoderma lucidum, Navesporus floccosa and Phellinus rimosus occurring in South India. Pharmaceutical Biology, 2003; 41(8): 564-567.
  • 17. Smania A(Jr), Delle MF, Smania EFA, Cuneo RS: Antibacterial activity of steroidal compounds isolated from Ganoderma applanatum (Pers.) Pat. (Aphyllophoromycetideae) fruit body. International Journal of Medicinal Mushrooms, 1999; 1: 325-330.
  • 18. Smania EFA, Delle MF, Yunes RA, Paulert R, Smania A(Jr): Antimicrobial activity of methyl australate from Ganoderma australe. Brazilian Journal of Pharmacognosy, 2007; 17(1): 14-16.
  • 19. Yang BK, Kim DH, Jeong SC, Das S, Choi YS, Shin JS, Song SC, Song CH: Hypoglycemic effect of a Lentinus edodes exo-polymer produced from a submerged mycelial culture. Bioscience Biotechnology and Biochemistry, 2002; 66(5): 937-942.
  • 20. Yoon SY, Eo SK, Kim YS, Lee CK, Han SS: Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Archives of Pharmacal Research. 1994; 17(6): 438-442